Displaying 11 - 20 of 908 results
-
Specify brand advice guidance – updated July 2023Refreshed guidelines for the application of specify brand advice (SBA) for medicines within electronic systems.
-
Patient experience surveys: flyer/poster for patientsThese documents can be used as a flyer or poster for patients to promote the patient experience survey in hospitals, PHOs and general practices. They are available in a range of languages.
-
Aotearoa New Zealand Tall Man lettering list (October 2023)The Aotearoa New Zealand Tall Man lettering list (updated October 2023) includes look-alike, sound-alike medicine names that have been predicted to pose the greatest risk to patient safety.
-
Statement of Performance Expectations | Ngā Paearu Mahi 2024/25The Statement of Performance Expectations for Te Tāhū Hauora Health Quality & Safety Commission for the period 1 July 2024 to 30 June 2025.
-
Rehabilitation collaborative review: 1 year on | He arotakenga haumanu ngātahi: 1 tau neiA review of the rehabilitation collaborative, 1 year on.
-
Thematic analysis of maternity adverse events reported 1 July 2018–30 June 2023This report is an analysis of maternity-specific data from a 5-year period (1 July 2018–30 June 2023).
-
Sixteenth Annual Report of the Perinatal and Maternal Mortality Review Committee | Te Pūrongo ā-Tau Tekau mā Ono o te Komiti Arotake Mate Pēpi, Mate Whaea HokiThe Sixteenth Annual Report of the Perinatal and Maternal Mortality Review Committee | Te Pūrongo ā-Tau Tekau mā Ono o te Komiti Arotake Mate Pēpi, Mate Whaea Hoki.
-
Equity scorecardThis equity scorecard was developed as a tool to support you in your learning and help identify areas that might need more work or reflection to enable you to deliver on equity and comply with the principles of Te Tiriti o Waitangi.
-
Mental health and addiction severity assessment code (SAC) examples 2024Mental health and addiction Severity Assessment Code (SAC) examples for adverse event reporting.